The great Greeks of Regeneron

In an interview with Kathimerini on April 26, Christos Kyratsous, vice president of research, infectious diseases and viral vector technologies at Regeneron Pharmaceuticals, said the company was optimistic it could develop a coronavirus treatment by fall.

Keywords
Τυχαία Θέματα
Greeks,Regeneron